Long-term prognosis and its associated predictive factors in patients with eosinophilic gastroenteritis

作     者：Kai-Wen Li Ge-Chong Ruan Shuang Liu Tian-Ming Xu Ye Ma Wei-Xun Zhou Wei Liu Peng-Yu Zhao Zhi-Rong Du Ji Li Jing-Nan Li 

作者机构：Department of GastroenterologyChinese Academy of Medical Sciences and Peking Union Medical College HospitalBeijing 100730China Department of AllergyChinese Academy of Medical Sciences and Peking Union Medical College HospitalBeijing 100730China Department of PathologyChinese Academy of Medical Sciences and Peking Union Medical College HospitalBeijing 100730China Department of RadiologyChinese Academy of Medical Sciences and Peking Union Medical College HospitalBeijing 100730China Affairs OfficeChinese Academy of Medical Sciences and Peking Union Medical College Hospital(West campus)Beijing 100032China 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2024年第30卷第2期

页      面：146-157页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：National High Level Hospital Clinical Research Funding,No.2022-PUMCH-B-022 CAMS Innovation Fund for Medical Sciences,No.CIFMS 2021-1-I2M-003 and Undergraduate Innovation Program,No.2023zglc06076 

主　　题：Eosinophilic gastroenteritis Prognosis Relapse Glucocorticoid Glucocorticoid dependence 

摘      要：BACKGROUND Eosinophilic gastroenteritis(EGE)is a chronic recurrent disease with abnormal eosinophilic infiltration in the gastrointestinal *** remain the most common treatment ***,disease relapse and glucocorticoid dependence remain notable *** date,few studies have illuminated the prognosis of EGE and risk factors for disease *** To describe the clinical characteristics of EGE and possible predictive factors for disease relapse based on long-term *** This was a retrospective cohort study of 55 patients diagnosed with EGE admitted to one medical center between 2013 and *** records were collected and ***-Meier curves and log-rank tests were conducted to reveal the risk factors for long-term relapse-free survival(RFS).RESULTS EGE showed a median onset age of 38 years and a slight female predominance(56.4%).The main clinical symptoms were abdominal pain(89.1%),diarrhea(61.8%),nausea(52.7%),distension(49.1%)and vomiting(47.3%).Forty-three(78.2%)patients received glucocorticoid treatment,and compared with patients without glucocorticoid treatments,they were more likely to have elevated serum immunoglobin E(IgE)(86.8%vs 50.0%,P=0.022)and descending duodenal involvement(62.8%vs 27.3%,P=0.046)at *** a median follow-up of 67 mo,all patients survived,and 56.4%had at least one *** variables at baseline might have been associated with the overall RFS rate,including age at diagnosis24 kg/m^(2)(HR 0.3922,95%CI:0.1916-0.8027,P=0.014),disease duration from symptom onset to diagnosis3.5 mo(HR 2.4725,95%CI:1.220-5.0110,P=0.011),vomiting(HR 3.1259,95%CI:1.5246-6.4093,P=0.001),total serum IgE300 KU/L at diagnosis(HR 0.2773,95%CI:0.1204-0.6384,P=0.022)and glucocorticoid treatment(HR 6.1434,95%CI:2.8446-13.2676,P=0.003).CONCLUSION In patients with EGE,younger onset age,longer disease c